466 related articles for article (PubMed ID: 25737052)
41. Infection of immunodeficient horses with Sarcocystis neurona does not result in neurologic disease.
Sellon DC; Knowles DP; Greiner EC; Long MT; Hines MT; Hochstatter T; Tibary A; Dame JB
Clin Diagn Lab Immunol; 2004 Nov; 11(6):1134-9. PubMed ID: 15539518
[TBL] [Abstract][Full Text] [Related]
42. Antibody coefficients for the diagnosis of equine protozoal myeloencephalitis.
Furr M; Howe D; Reed S; Yeargan M
J Vet Intern Med; 2011; 25(1):138-42. PubMed ID: 21155894
[TBL] [Abstract][Full Text] [Related]
43. [Equine protozoal myeloencephalitis in the Netherlands? An overview].
Goehring LS; Sloet van Oldruitenborgh-Oosterbaan MM
Tijdschr Diergeneeskd; 2001 May; 126(10):346-51. PubMed ID: 11392988
[TBL] [Abstract][Full Text] [Related]
44. Serologic cross-reactivity between Sarcocystis neurona and Sarcocystis falcatula-like in experimentally infected Mongolian gerbils.
de Jesus RF; Borges-Silva W; Bezerra TL; Gondim LQ; Uzêda RS; Gondim LFP
Vet Parasitol; 2019 Dec; 276():108962. PubMed ID: 31704559
[TBL] [Abstract][Full Text] [Related]
45. Equine protozoal myeloencephalitis.
Madigan JE; Higgins RJ
Vet Clin North Am Equine Pract; 1987 Aug; 3(2):397-403. PubMed ID: 3113695
[TBL] [Abstract][Full Text] [Related]
46. Effect of intermittent oral administration of ponazuril on experimental Sarcocystis neurona infection of horses.
Mackay RJ; Tanhauser ST; Gillis KD; Mayhew IG; Kennedy TJ
Am J Vet Res; 2008 Mar; 69(3):396-402. PubMed ID: 18312139
[TBL] [Abstract][Full Text] [Related]
47. Prophylactic administration of ponazuril reduces clinical signs and delays seroconversion in horses challenged with Sarcocystis neurona.
Furr M; McKenzie H; Saville WJ; Dubey JP; Reed SM; Davis W
J Parasitol; 2006 Jun; 92(3):637-43. PubMed ID: 16884012
[TBL] [Abstract][Full Text] [Related]
48. Serologic responses of cats against experimental Sarcocystis neurona infections.
Dubey JP; Lindsay DS; Saville WJ
Vet Parasitol; 2002 Aug; 107(3):265-9. PubMed ID: 12127255
[TBL] [Abstract][Full Text] [Related]
49. Utility of 2 immunological tests for antemortem diagnosis of equine protozoal myeloencephalitis (Sarcocystis neurona Infection) in naturally occurring cases.
Johnson AL; Burton AJ; Sweeney RW
J Vet Intern Med; 2010; 24(5):1184-9. PubMed ID: 20707841
[TBL] [Abstract][Full Text] [Related]
50. Experimental induction of equine protozoan myeloencephalitis (EPM) in the horse: effect of Sarcocystis neurona sporocyst inoculation dose on the development of clinical neurologic disease.
Sofaly CD; Reed SM; Gordon JC; Dubey JP; Ogleebee MJ; Njoku CJ; Grover DL; Saville WJ
J Parasitol; 2002 Dec; 88(6):1164-70. PubMed ID: 12537112
[TBL] [Abstract][Full Text] [Related]
51. Immunohistochemical study to demonstrate Sarcocystis neurona in equine protozoal myeloencephalitis.
Hamir AN; Moser G; Galligan DT; Davis SW; Granstrom DE; Dubey JP
J Vet Diagn Invest; 1993 Jul; 5(3):418-22. PubMed ID: 8373858
[TBL] [Abstract][Full Text] [Related]
52. Equine protozoal myeloencephalitis: antigen analysis of cultured Sarcocystis neurona merozoites.
Granstrom DE; Dubey JP; Davis SW; Fayer R; Fox JC; Poonacha KB; Giles RC; Comer PF
J Vet Diagn Invest; 1993 Jan; 5(1):88-90. PubMed ID: 8466988
[TBL] [Abstract][Full Text] [Related]
53. Inoculation of Sarcocystis neurona merozoites into the central nervous system of horses.
Lindsay DS; Dykstra CC; Williams A; Spencer JA; Lenz SD; Palma K; Dubey JP; Blagburn BL
Vet Parasitol; 2000 Sep; 92(2):157-63. PubMed ID: 10946139
[TBL] [Abstract][Full Text] [Related]
54.
Hay AN; Witonsky SG; Lindsay DS; LeRoith T; Zhu J; Kasmark L; Leeth CM
J Parasitol; 2019 Apr; 105(2):371-378. PubMed ID: 31033388
[No Abstract] [Full Text] [Related]
55. Utilization of stress in the development of an equine model for equine protozoal myeloencephalitis.
Saville WJ; Stich RW; Reed SM; Njoku CJ; Oglesbee MJ; Wunschmann A; Grover DL; Larew-Naugle AL; Stanek JF; Granstrom DE; Dubey JP
Vet Parasitol; 2001 Feb; 95(2-4):211-22. PubMed ID: 11223201
[TBL] [Abstract][Full Text] [Related]
56. Sarcocyst Development in Raccoons (Procyon lotor) Inoculated with Different Strains of Sarcocystis neurona Culture-Derived Merozoites.
Dryburgh EL; Marsh AE; Dubey JP; Howe DK; Reed SM; Bolten KE; Pei W; Saville WJ
J Parasitol; 2015 Aug; 101(4):462-7. PubMed ID: 25811893
[TBL] [Abstract][Full Text] [Related]
57. Sarcocystis neurona n. sp. (Protozoa: Apicomplexa), the etiologic agent of equine protozoal myeloencephalitis.
Dubey JP; Davis SW; Speer CA; Bowman DD; de Lahunta A; Granstrom DE; Topper MJ; Hamir AN; Cummings JF; Suter MM
J Parasitol; 1991 Apr; 77(2):212-8. PubMed ID: 1901359
[TBL] [Abstract][Full Text] [Related]
58. Cell-mediated immune responses in horses with equine protozoal myeloencephalitis.
Spencer JA; Ellison SE; Guarino AJ; Blagburn BL
J Parasitol; 2004 Apr; 90(2):428-30. PubMed ID: 15165077
[TBL] [Abstract][Full Text] [Related]
59. Immunoconversion against Sarcocystis neurona in normal and dexamethasone-treated horses challenged with S. neurona sporocysts.
Cutler TJ; MacKay RJ; Ginn PE; Gillis K; Tanhauser SM; LeRay EV; Dame JB; Greiner EC
Vet Parasitol; 2001 Feb; 95(2-4):197-210. PubMed ID: 11223200
[TBL] [Abstract][Full Text] [Related]
60. Determination of the activity of pyrimethamine, trimethoprim, sulfonamides, and combinations of pyrimethamine and sulfonamides against Sarcocystis neurona in cell cultures.
Lindsay DS; Dubey JP
Vet Parasitol; 1999 Apr; 82(3):205-10. PubMed ID: 10348099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
